Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

RNA Editing of Tumor Suppressor Mir-26a Promotes Malignant Progenitor Propagation in Chronic Myeloid Leukemia

Raymond H Diep, Qingfei Jiang, PhD, Jane Isquith, MS, Maria A. Zipeto, PhD, Jessica Pham, Nathan Delos Santos, BS, Julisia Chau, B.S., Sheldon Morris, MD MPH, Catriona Jamieson, MD PhD

Blood (2018) 132 (Supplement 1): 2611.

https://doi.org/10.1182/blood-2018-99-116988

Published: 2018

Journal Articles

NSD1 and NSD2 Transcriptional Levels Might Predict Clinical Outcome in AML Patients

Virginia Mara De Deus Wagatsuma, PhD, Diego Antonio Pereira-Martins, MSc, Mariane Cristina Do Nascimento, BSc, Silvia Elena Sanchez Mendoza, Antonio R. Lucena-Araujo, PhD, Aleide Lima, MSc, Felipe Saldanha-Araujo, PhD, Fabio Pitella, PhD, Fabiola Traina, MD PhD, Maria Isabel A Madeira, MSc, MD, Lorena Lobo Figueiredo-Pontes, MD PhD, Eduardo Magalhães Rego, MD PhD

Blood (2018) 132 (Supplement 1): 5257.

https://doi.org/10.1182/blood-2018-99-119411

Published: 2018

Journal Articles

RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis

Qingfei Jiang, PhD, Maria A. Zipeto, PhD, Nathaniel Delos Santos, BS, Heather Leu, BS, Jane Isquith, MS, Etienne Atien, BS, Catriona Jamieson, MD PhD

Blood (2016) 128 (22): 887.

https://doi.org/10.1182/blood.V128.22.887.887

Published: 2016

Journal Articles

Long Non-Coding RNA Induces De Novo Myelodysplastic Syndrome through Epigenetic Regulation

Maitri Shah, MS, Valentina Pilecki, Roxana Redis, Linda Fabris, Maria Ciccone, MD, Cristina Ivan, Ioana Berindan-Neago, Riccardo Fodde, Carlos E. Bueso-Ramos, MD, Mihai Gagea, Guillermo Garcia Manero, George Calin, MDPhD

Blood (2015) 126 (23): 1640.

https://doi.org/10.1182/blood.V126.23.1640.1640

Published: 2015

Journal Articles

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

Hao Huang, PhD, Xi Jiang, PhD, Jinhua Wang, Yuanyuan Li, Ping Chen, Stephen Arnovitz, Shenglai Li, Yungui Wang, Hengyou Weng, PhD, Mary Elizabeth Neilly, Zejuan Li, MD PhD, Jianjun Chen, PhD

Blood (2014) 124 (21): 1011.

https://doi.org/10.1182/blood.V124.21.1011.1011

Published: 2014

Journal Articles

Silencing c-Myc Using Myc Inhibitor JQ1 and EZH2 Inhibitor DZNep Blocks Converging Survival Signals in Aggressive B-Cell Lymphomas

Xiaohong Zhao, PhD, Tint Lwin, MD, PhD, Xinwei Zhang, MD, Andy Huang, Jian Wang, Victor E. Marquez, PhD, Selina Chen-Kiang, PhD, James E Bradner, MD, William S. Dalton, PhD, MD, Eduardo M. Sotomayor, MD, Jianguo Tao, MD, PhD

Blood (2012) 120 (21): 4618.

https://doi.org/10.1182/blood.V120.21.4618.4618

Published: 2012

Journal Articles

The TAL1 Complex Represses the FBXW7 Tumor Suppressor Through Mir-223 in Human T-Cell Acute Lymphoblastic Leukemia

Marc R Mansour, MD FRCPath, Takaomi Sanda, MD, PhD, Lee N Lawton, PhD, Xiaoyu Li, MD, PhD, Taras Kreslavsky, PhD, Carl Novina, MD PhD, Harald von Boehmer, MD PhD, Richard Young, PhD, A. Thomas Look, M.D.

Blood (2012) 120 (21): 1296.

https://doi.org/10.1182/blood.V120.21.1296.1296

Published: 2012

Journal Articles

Dysregulated MicroRNA Affects Pathways and Targets of Biological Relevance in Nasal-Type Natural Killer/T-Cell Lymphoma

Wee-Joo Chng, M.B.Ch.B, Junli Yan, PhD, Gaofeng Huang, PhD, Viknesvaran Selvarajan, BSc, Jim Tay, BSc, Baohong Lin, BSc, Chonglei Bi, B.sc., Joy Tan, BSc, Siok-Bian Ng, MB ChB

Blood (2011) 118 (21): 2637.

https://doi.org/10.1182/blood.V118.21.2637.2637

Published: 2011

Journal Articles

Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4,

Emanuela M. Ghia, PhD, Lillian Werner, Danelle F. James, M.D., Donna Neuberg, ScD, Laura G Corral, Senior, Scientist, Laura Z. Rassenti, Ph.D., Carlo M. Croce, MD, Thomas J. Kipps, M.D., Ph.D

Blood (2011) 118 (21): 3885.

https://doi.org/10.1182/blood.V118.21.3885.3885

Published: 2011

Journal Articles

NPM-ALK Oncogene Upregulates the Expression of Inducible Nitric Oxide Synthase in T-Cell Lymphoma Through STAT3/MicroRNA-26a-Dependent Mechanism

Haifeng Zhu, PhD, Hesham M. Amin, MD, MSc

Blood (2011) 118 (21): 1383.

https://doi.org/10.1182/blood.V118.21.1383.1383

Published: 2011

Journal Articles

Mirna Expression Profile of Microvesicles Derived From K562 Cells

Wei Xiong, Xiaomei Chen, Fang Liu, Xiangjun Chen, Cong Lu, Huiyu Li, Shiang Huang, MD

Blood (2011) 118 (21): 4411.

https://doi.org/10.1182/blood.V118.21.4411.4411

Published: 2011

Journal Articles

MicroRNAs Expression signatures of microvesicles Derived-From Three Different Leukemia Cell Lines

Xiaomei Chen, Wei Xiong, Dongmei Guo, Junfeng Wang, Juanjuan Li, Xing Xin, Shiang Huang, MD, Huiyu Li

Blood (2011) 118 (21): 4649.

https://doi.org/10.1182/blood.V118.21.4649.4649

Published: 2011

Journal Articles

MicroRNA profiles of t(14;18)–negative follicular lymphoma support a late germinal center B-cell phenotype

Blood (2011) 118 (20): 5550–5558.

https://doi.org/10.1182/blood-2011-06-361972

Published: 2011

Includes: Supplemental data

Journal Articles

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

Rashmi S. Goswami, BSc, MD, FRCPC, Levi Waldron, Ph.D., Patricia P Reis, Ph.D., Yali Xuan, Wei Xu, Ph.D., John Kuruvilla, David Good, MD, Denis Bailey, MD, Alanna Church, MD, Tara Baetz, MD, David LeBrun, MD, Raymond Lai, MD, Ph.D., Laurie Sehn, MD, MPH, Pedro Farinha, MD, Randy D. Gascoyne, MD, Michael Crump, MD, FRCPC, Igor Jurisica, Ph.D., Suzanne Kamel-Reid, Ph.D.

Blood (2010) 116 (21): 800.

https://doi.org/10.1182/blood.V116.21.800.800

Published: 2010

Journal Articles

Dysregulation of miRNAs In AL Amyloidosis

Liangping Weng, MD, Brain Spencer, Pam Soo Hoo, Lawreen Connors, Carl O'Hara, David C Seldin, MD, PhD

Blood (2010) 116 (21): 4648.

https://doi.org/10.1182/blood.V116.21.4648.4648

Published: 2010

Journal Articles

Functional Implications of miRNAs in Acute Myeloid Leukemia (AML) by miRNA-mRNA Expression Profiling.

Violaine Havelange, MD, Stefano Volinia, MD, Michael Andreeff, MD, PhD, Guido Marcucci, MD, Carlo M. Croce, MD, Ramiro Garzon, MD

Blood (2009) 114 (22): 1634.

https://doi.org/10.1182/blood.V114.22.1634.1634

Published: 2009

Journal Articles

MicroRNA Expression Contributes to Hypoxia-Inducible Factor-1a-Induced Differentiation of Myeloid Leukemic Cells.

Ming He, Bo Zhang, Qianqian Yin, Meng Guo, Qian Zhao, Guo-Qiang Chen

Blood (2009) 114 (22): 1007.

https://doi.org/10.1182/blood.V114.22.1007.1007

Published: 2009

Journal Articles

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

Sandrine Sander, Lars Bullinger, Kay Klapproth, Katja Fiedler, Hans A. Kestler, Thomas F. E. Barth, Peter Möller, Stephan Stilgenbauer, Jonathan R. Pollack, Thomas Wirth

Blood (2008) 112 (10): 4202–4212.

https://doi.org/10.1182/blood-2008-03-147645

Published: 2008

Includes: Supplemental data

Journal Articles

An Atlas of the MicroRNA Genome in Human DLBCL.

Shailaja Karanti, Aswani Bolla, Ciara Dillon, Ryan S. Robetorye, MD PhD, Ricardo C.T. Aguiar, MD PhD

Blood (2007) 110 (11): 563.

https://doi.org/10.1182/blood.V110.11.563.563

Published: 2007

Journal Articles

Association of MicroRNA Expression Profiles with Karyotype in Acute Myeloid Leukaemias Revealed by Real-Time PCR and In Situ Hybridisation.

Amanda Dixon-McIver, Phil East, Charles A. Mein, Jean-Baptiste Cazier, Gael Molloy, Tracy Chaplin, T. Andrew Lister, Bryan Young, Silvana Debernardi

Blood (2007) 110 (11): 105.

https://doi.org/10.1182/blood.V110.11.105.105

Published: 2007

NARROW

RNA Editing of Tumor Suppressor Mir-26a Promotes Malignant Progenitor Propagation in Chronic Myeloid Leukemia

NSD1 and NSD2 Transcriptional Levels Might Predict Clinical Outcome in AML Patients

RNA Editing Enzyme ADAR1 Accelerates Normal Hematopoiesis Cell Cycle By Regulating microRNA Biogenesis

Long Non-Coding RNA Induces De Novo Myelodysplastic Syndrome through Epigenetic Regulation

Identification of MLL-Fusion/Myc⊣miR-26a/Mir-29a⊣Tet1 Signaling Circuit in MLL -Rearranged Leukemia

Silencing c-Myc Using Myc Inhibitor JQ1 and EZH2 Inhibitor DZNep Blocks Converging Survival Signals in Aggressive B-Cell Lymphomas

The TAL1 Complex Represses the FBXW7 Tumor Suppressor Through Mir-223 in Human T-Cell Acute Lymphoblastic Leukemia

Dysregulated MicroRNA Affects Pathways and Targets of Biological Relevance in Nasal-Type Natural Killer/T-Cell Lymphoma

Treatment of Chronic Lymphocytic Leukemia Patients with Lenalidomide Induces Down-Regulation of miR342-3p Associated with Over-Expression of Tumor Suppressor RASSF4,

NPM-ALK Oncogene Upregulates the Expression of Inducible Nitric Oxide Synthase in T-Cell Lymphoma Through STAT3/MicroRNA-26a-Dependent Mechanism

Mirna Expression Profile of Microvesicles Derived From K562 Cells

MicroRNAs Expression signatures of microvesicles Derived-From Three Different Leukemia Cell Lines

MicroRNA profiles of t(14;18)–negative follicular lymphoma support a late germinal center B-cell phenotype

Comparing MicroRNA Expression In Aggressive and Indolent Non-Hodgkin Lymphomas Identifies a Prognostic Signature for Mantle Cell Lymphoma

Dysregulation of miRNAs In AL Amyloidosis

Functional Implications of miRNAs in Acute Myeloid Leukemia (AML) by miRNA-mRNA Expression Profiling.

MicroRNA Expression Contributes to Hypoxia-Inducible Factor-1a-Induced Differentiation of Myeloid Leukemic Cells.

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

An Atlas of the MicroRNA Genome in Human DLBCL.

Association of MicroRNA Expression Profiles with Karyotype in Acute Myeloid Leukaemias Revealed by Real-Time PCR and In Situ Hybridisation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only